Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.01
MDAS's Cash to Debt is ranked lower than
64% of the 2641 Companies
in the Global Health Information Services industry.

( Industry Median: 7.06 vs. MDAS: 0.01 )
MDAS' s 10-Year Cash to Debt Range
Min: 0   Max: No Debt
Current: 0.01

Equity to Asset 0.26
MDAS's Equity to Asset is ranked lower than
57% of the 2471 Companies
in the Global Health Information Services industry.

( Industry Median: 0.59 vs. MDAS: 0.26 )
MDAS' s 10-Year Equity to Asset Range
Min: -0.6   Max: 0.56
Current: 0.26

-0.6
0.56
Interest Coverage 1.02
MDAS's Interest Coverage is ranked lower than
64% of the 1646 Companies
in the Global Health Information Services industry.

( Industry Median: 10000.00 vs. MDAS: 1.02 )
MDAS' s 10-Year Interest Coverage Range
Min: 0.59   Max: 9999.99
Current: 1.02

0.59
9999.99
F-Score: 5
Z-Score: 0.82
M-Score: -2.54
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 6.45
MDAS's Operating margin (%) is ranked higher than
72% of the 2607 Companies
in the Global Health Information Services industry.

( Industry Median: 5.74 vs. MDAS: 6.45 )
MDAS' s 10-Year Operating margin (%) Range
Min: -4.99   Max: 17.56
Current: 6.45

-4.99
17.56
Net-margin (%) -2.83
MDAS's Net-margin (%) is ranked higher than
55% of the 2607 Companies
in the Global Health Information Services industry.

( Industry Median: 3.65 vs. MDAS: -2.83 )
MDAS' s 10-Year Net-margin (%) Range
Min: -8.21   Max: 16.69
Current: -2.83

-8.21
16.69
ROE (%) -4.28
MDAS's ROE (%) is ranked higher than
54% of the 2536 Companies
in the Global Health Information Services industry.

( Industry Median: 6.80 vs. MDAS: -4.28 )
MDAS' s 10-Year ROE (%) Range
Min: -7.36   Max: 20.26
Current: -4.28

-7.36
20.26
ROA (%) -1.23
MDAS's ROA (%) is ranked higher than
57% of the 2651 Companies
in the Global Health Information Services industry.

( Industry Median: 3.48 vs. MDAS: -1.23 )
MDAS' s 10-Year ROA (%) Range
Min: -2.45   Max: 14.99
Current: -1.23

-2.45
14.99
ROC (Joel Greenblatt) (%) 28.77
MDAS's ROC (Joel Greenblatt) (%) is ranked higher than
70% of the 2620 Companies
in the Global Health Information Services industry.

( Industry Median: 30.94 vs. MDAS: 28.77 )
MDAS' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -28.34   Max: 148.36
Current: 28.77

-28.34
148.36
Revenue Growth (3Y)(%) 6.10
MDAS's Revenue Growth (3Y)(%) is ranked higher than
72% of the 2039 Companies
in the Global Health Information Services industry.

( Industry Median: 5.30 vs. MDAS: 6.10 )
MDAS' s 10-Year Revenue Growth (3Y)(%) Range
Min: 0   Max: 23.6
Current: 6.1

0
23.6
EBITDA Growth (3Y)(%) -0.40
MDAS's EBITDA Growth (3Y)(%) is ranked higher than
65% of the 1678 Companies
in the Global Health Information Services industry.

( Industry Median: 6.50 vs. MDAS: -0.40 )
MDAS' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0   Max: 72.3
Current: -0.4

0
72.3
EPS Growth (3Y)(%) 8.00
MDAS's EPS Growth (3Y)(%) is ranked higher than
74% of the 1540 Companies
in the Global Health Information Services industry.

( Industry Median: 6.40 vs. MDAS: 8.00 )
MDAS' s 10-Year EPS Growth (3Y)(%) Range
Min: 0   Max: 8
Current: 8

0
8
» MDAS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

MDAS Guru Trades in Q1 2014

Mario Gabelli 11,500 sh (New)
Steven Cohen 1,099,241 sh (+53.59%)
Joel Greenblatt 34,198 sh (+33.27%)
Paul Tudor Jones Sold Out
Jim Simons 60,300 sh (-80.54%)
» More
Q2 2014

MDAS Guru Trades in Q2 2014

Paul Tudor Jones 9,800 sh (New)
Joel Greenblatt 52,010 sh (+52.08%)
Mario Gabelli 11,500 sh (unchged)
Steven Cohen 245,600 sh (unchged)
Jim Simons Sold Out
» More
Q3 2014

MDAS Guru Trades in Q3 2014

Paul Tudor Jones 25,815 sh (+163.42%)
Steven Cohen 538,000 sh (+119.06%)
Mario Gabelli 12,500 sh (+8.70%)
Joel Greenblatt 56,371 sh (+8.38%)
» More
Q4 2014

MDAS Guru Trades in Q4 2014

Paul Tudor Jones 55,316 sh (+114.28%)
Joel Greenblatt 58,929 sh (+4.54%)
Mario Gabelli 12,500 sh (unchged)
Steven Cohen Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with MDAS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
Forward P/E 15.60
MDAS's Forward P/E is ranked higher than
90% of the 2946 Companies
in the Global Health Information Services industry.

( Industry Median: 0.00 vs. MDAS: 15.60 )
N/A
P/B 2.70
MDAS's P/B is ranked higher than
68% of the 2946 Companies
in the Global Health Information Services industry.

( Industry Median: 3.63 vs. MDAS: 2.70 )
MDAS' s 10-Year P/B Range
Min: 1.26   Max: 4.39
Current: 2.7

1.26
4.39
P/S 1.70
MDAS's P/S is ranked higher than
67% of the 2946 Companies
in the Global Health Information Services industry.

( Industry Median: 2.70 vs. MDAS: 1.70 )
MDAS' s 10-Year P/S Range
Min: 0.92   Max: 4.22
Current: 1.7

0.92
4.22
PFCF 16.40
MDAS's PFCF is ranked higher than
86% of the 2946 Companies
in the Global Health Information Services industry.

( Industry Median: 212.81 vs. MDAS: 16.40 )
MDAS' s 10-Year PFCF Range
Min: 5.2   Max: 46.77
Current: 16.4

5.2
46.77
POCF 8.84
MDAS's POCF is ranked higher than
90% of the 2946 Companies
in the Global Health Information Services industry.

( Industry Median: 32.90 vs. MDAS: 8.84 )
MDAS' s 10-Year POCF Range
Min: 3.83   Max: 25.22
Current: 8.84

3.83
25.22
EV-to-EBIT 45.23
MDAS's EV-to-EBIT is ranked higher than
70% of the 2946 Companies
in the Global Health Information Services industry.

( Industry Median: 45.12 vs. MDAS: 45.23 )
MDAS' s 10-Year EV-to-EBIT Range
Min: -107.8   Max: 47
Current: 45.23

-107.8
47
Current Ratio 0.66
MDAS's Current Ratio is ranked lower than
59% of the 2527 Companies
in the Global Health Information Services industry.

( Industry Median: 1.91 vs. MDAS: 0.66 )
MDAS' s 10-Year Current Ratio Range
Min: 0.55   Max: 2.52
Current: 0.66

0.55
2.52
Quick Ratio 0.66
MDAS's Quick Ratio is ranked lower than
58% of the 2527 Companies
in the Global Health Information Services industry.

( Industry Median: 1.79 vs. MDAS: 0.66 )
MDAS' s 10-Year Quick Ratio Range
Min: 0.55   Max: 2.52
Current: 0.66

0.55
2.52
Days Sales Outstanding 64.74
MDAS's Days Sales Outstanding is ranked higher than
78% of the 2946 Companies
in the Global Health Information Services industry.

( Industry Median: 87.14 vs. MDAS: 64.74 )
MDAS' s 10-Year Days Sales Outstanding Range
Min: 47.01   Max: 93.29
Current: 64.74

47.01
93.29

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 0.90
MDAS's Price/DCF (Projected) is ranked higher than
94% of the 2946 Companies
in the Global Health Information Services industry.

( Industry Median: 0.00 vs. MDAS: 0.90 )
MDAS' s 10-Year Price/DCF (Projected) Range
Min: 0.71   Max: 1.72
Current: 0.9

0.71
1.72
Price/Median PS Value 0.90
MDAS's Price/Median PS Value is ranked higher than
89% of the 2946 Companies
in the Global Health Information Services industry.

( Industry Median: 1.40 vs. MDAS: 0.90 )
MDAS' s 10-Year Price/Median PS Value Range
Min: 0.48   Max: 1.88
Current: 0.9

0.48
1.88
Earnings Yield (Greenblatt) 2.20
MDAS's Earnings Yield (Greenblatt) is ranked higher than
63% of the 2583 Companies
in the Global Health Information Services industry.

( Industry Median: 3.20 vs. MDAS: 2.20 )
MDAS' s 10-Year Earnings Yield (Greenblatt) Range
Min: 2.1   Max: 5.1
Current: 2.2

2.1
5.1
Forward Rate of Return (Yacktman) 36.84
MDAS's Forward Rate of Return (Yacktman) is ranked higher than
95% of the 1141 Companies
in the Global Health Information Services industry.

( Industry Median: 11.82 vs. MDAS: 36.84 )
MDAS' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 5.3   Max: 37.6
Current: 36.84

5.3
37.6

Business Description

Industry: Application Software » Health Information Services
Compare: » details
Traded in other countries:58M.Germany,
MedAssets Inc was incorporated in 1999. It is a financial and performance improvement company providing technology-enabled products and services that, together, help mitigate the increasing financial challenges faced by hospitals, health systems, and other non-acute healthcare providers. Its solutions are designed to reduce the total cost of care delivery, enhance operational efficiency, align clinical delivery of physicians and staff to advance care coordination, and improve revenue performance mainly for hospitals and health systems. The Company's solutions integrate with its clients' existing operations and enterprise software systems, and require minimal upfront costs or capital expenditures for its clients. Its technology-enabled solutions are delivered through company-hosted software, sometimes referred to as software as a service or Web-based applications, supported by implementation, process improvement consulting and outsourced services, as well as enterprise-wide sales and client management support. The Company manages its business through two business segments, Spend and Clinical Resource Management (CM) and Revenue Cycle Management (RCM). Within the SCM segment it provides a comprehensive suite of cost management services, supply chain analytics and data capabilities that help its clients reduce their total cost of care delivery, enhance their operational efficiency and align their clinicians' delivery of care with advance care coordination. Its solutions lower operating costs through compliance to its strategic sourcing of supplies and purchased services at discounted prices, supply chain outsourcing and procurement services capabilities. It also help to improve care processes and reduce care variations through the use of its clinical and process improvement consulting services, workforce optimization solutions and business analytics and intelligence tools. The Company's RCM segment is a provider of revenue cycle management solutions to healthcare providers, mainly hospitals and health systems. It provides SaaS or Web-based software and technology-enabled services designed to improve revenue performance for healthcare organizations through patient access and financial responsibility, clinical documentation, charge capture and revenue integrity, pricing analysis, claims processing and denials management, payor contract management, extended business office revenue recovery, accounts receivable services and outsourcing. As of December 31, 2013, the Company's client base included more than 4,400 acute care hospitals and approximately 122,000 ancillary or non-acute provider locations. The Company competes with Allscripts Corporation, Epic Systems Corporation, McKesson Corporation, Siemens AG; Accenture Ltd., Accretive Health, Inc., Deloitte & Touche LLP, Ernst & Young LLP, Craneware Inc., Emdeon Inc. and among others. The Company is subject to federal and state laws and regulations designed to protect patients, government
» More Articles for MDAS

Headlines

Articles On GuruFocus.com
Weekly CEO Buys Highlight: APD, MDAS, PNNT, MDU, SRV Feb 23 2015 
Weekly CEO Sells Highlight: Amazon.com Inc, Atmel Corporation, Monolithic Power Systems Inc, MedAsse Nov 10 2013 
Steven Cohen Increases Two High-Growth Positions - OCZ Technology and MedAssets Inc. Apr 17 2012 
MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 9,000 Shares Mar 08 2011 
MEDASSETS, INC. Reports Operating Results (10-K) Mar 01 2011 
MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 15,000 Shares Feb 09 2011 
MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 15,000 Shares Jan 05 2011 
MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 15,000 Shares Dec 08 2010 
MEDASSETS, INC. (MDAS) Chairman, President and CEO John A Bardis sells 40,000 Shares Dec 01 2010 
MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 15,000 Shares Nov 09 2010 


More From Other Websites
MEDASSETS INC Files SEC form 8-K, Change in Directors or Principal Officers Apr 23 2015
MedAssets Expands Relationship With Vanderbilt University Medical Center to Include Lean Healthcare... Apr 23 2015
MedAssets Expands Relationship With Vanderbilt University Medical Center to Include Lean Healthcare... Apr 23 2015
Photo Release -- MedAssets Names Young People Matter the 2014 Norman Borlaug Humanitarian Award... Apr 21 2015
Can Healthways (HWAY) Pull a Surprise this Earnings? - Analyst Blog Apr 21 2015
MedAssets Healthcare Business Summit Focuses on the Future of Healthcare Apr 16 2015
MedAssets Healthcare Business Summit Focuses on the Future of Healthcare Apr 16 2015
MedAssets: A Strong Sell on Tepid View, Estimate Revision - Analyst Blog Apr 09 2015
Healthways Completes Evaluation of Strategic Alternatives - Analyst Blog Apr 01 2015
MedAssets to Report First Quarter 2015 Financial Results on Wednesday, April 29th Mar 31 2015
MedAssets to Report First Quarter 2015 Financial Results on Wednesday, April 29th Mar 31 2015
MEDASSETS INC Financials Mar 26 2015
Healthways (HWAY) Rides High on Strategic Partnerships - Analyst Blog Mar 19 2015
Chuck Garner Promoted to Chief Strategy and Transformation Officer; Anthony Colaluca Joins MedAssets... Mar 17 2015
MEDASSETS INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD... Mar 17 2015
Chuck Garner Promoted to Chief Strategy and Transformation Officer; Anthony Colaluca Joins MedAssets... Mar 17 2015
Healthways and MedAssets to Build the First Nationwide Network of Lifestyle Medicine Centers to... Mar 17 2015
Healthways and MedAssets to Build the First Nationwide Network of Lifestyle Medicine Centers to... Mar 17 2015
Healthways and MedAssets to Build the First Nationwide Network of Lifestyle Medicine Centers to... Mar 17 2015
Hire Heroes USA to be Recognized at America's Future Series Five Star Award Ceremony and Military... Mar 12 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK